Tyler E. Jacks - Cancer Science

Author Information

Tyler E. Jacks is a prominent researcher affiliated with the Koch Institute for Integrative Cancer Research and the Department of Biology at the Massachusetts Institute of Technology (MIT) in Cambridge, MA, USA. He is also associated with the Howard Hughes Medical Institute at MIT. His research primarily focuses on cancer biology, with significant contributions to understanding cancer neuroscience, lung adenocarcinoma, and pancreatic cancer. His work often explores the genetic and immunological aspects of cancer, aiming to develop innovative therapeutic strategies.

Research Contributions

Tyler E. Jacks has made substantial contributions to cancer research, with a focus on the interplay between cancer and the immune system. His recent works include exploring therapeutic avenues for cancer neuroscience, understanding the role of GATA4 in tumor suppression, and modeling genetic subtypes of lung adenocarcinoma using advanced organoid platforms. He has also investigated the mechanisms of immune escape in pancreatic cancer and the tumor extravasation process in brain cancer. His research is characterized by a translational approach, seeking to bridge laboratory findings with clinical applications.

Aliases

Throughout his career, Tyler E. Jacks has been referenced by several aliases, including T Jacks, T. Jacks, Tyler Jacks, and Tyler E Jacks. These variations appear in various publications and academic references.

Publication and Citation Metrics

Metric Value
Citation Count 117,420
h-index 153
Paper Count 530

Publications:

Partnered Content Networks

Relevant Topics